behavior disorders in children
|
|
- Kellie Norris
- 6 years ago
- Views:
Transcription
1 behavior disorders in children NHUNG T. TRAN, MD, FAAP DEVELOPMENTAL-BEHAVIORAL PEDIATRICS SCOTT & WHITE HEALTHCARE ASSOCIATE PROFESSOR TEXAS A&M HEALTH SCIENCE CENTER COLLEGE OF MEDICINE MARCH 23, 2013 SCOTT & WHITE 22 ND ANNUAL ROBERT E. MYERS, MD, LECTURESHIP IN PEDIATRICS
2 faculty disclosure Discussion will reference some pharmaceuticals that are not approved by the FDA for use in children and adolescents. I have no relevant financial relationships with the manufacturer(s) of any commercial product(s) and/or provider of commercial services discussed in this CME activity.
3 objectives To better recognize typical from atypical behaviors To know behavioral screening tools and how they can be used in clinical practice To understand the management of some behavioral disorders
4 the whole child HPI: severely hyperactive, impulsive, aggressive, not learning FHX: maternal grandmother is alcohol-dependent drinker; mother is at-risk drinker and has mild ID Prenatal HX: daily binge drinking until 5 months gestation, in an effort to abort mary
5 the whole child Features Partial FAS Phenotype Developmental Behavioral Medical Intellectual Disability, Language Disorder ADHD, ODD, insomnia Growth 10 th percentile Motor Psychosocial Fine motor deficits, dysgraphia Poor social cognition, parentchild conflicts
6 the whole child Treatment Partial FAS Phenotype Developmental Behavioral Medical Special Education under OHI, MR and SI ; ST Medications, counseling Close monitoring Motor Psychosocial OT (school) Social skills training; maternal mental health; case management
7 extrinsic and intrinsic factors Maternal depression Parental attitude Parenting stress Parent characteristics Parenting style Behavior problem Child characteristics Poverty Social network Maternal education Socio- Economic Temperament Medical disability Cognitive disability Behavior disorder
8 behavior disorders in children Why did he do that? Should I be worried? What is going on? What should I do?
9 why did he do that? A-B-C S OF BEHAVIORS
10 taking the behavioral history in the eyes of the beholder misery loves company
11 why did he do that? result in self-injury, injury to others, cause damage to the physical environment and/or interfere with the acquisition of new skills, and/or socially isolate the learner [Doss & Reichle, 1991] Described by Form Function Social motivation
12 why did he do that? Form Single form per episode Sequence or group of behaviors per episode Function To communicate, especially emotion To avoid or escape undesired/nonpreferred outcomes (attention, objects, activities) To gain access to desired/preferred outcomes (attention, objects, activities)
13 why did he do that? Social motivation - what is needed to affect the probability that behaviors will continue to occur in the future Socially motivated: requires others in the environment Non-socially motivated: does not require others in the environment, often to gain access to or avoid/escape internal stimuli
14 why did he do that? Ex. Ben with quadriplegic CP and severe dysarthria slaps himself in the face until the teacher takes him to the playground Form: self-injury Function: gain access to desired activity (i.e., play) Socially mediated: teacher positively reinforces the inappropriate behavior
15 why did he do that? Ex. Noah likes to bang objects to make loud noises Form: making loud noises (disruptive) Function: gain access to desired outcome (sensory) Non-socially motivated: sensory stimulation positively reinforces the inappropriate behavior
16 why did he do that? Ex. Beth bangs her head with an ear infection. Mom picks up to soothe, offers toys, goes to the doctor. Now Beth bangs her head often. Form: self-injury Function: gain access to desired outcome (mom s attention) Non-socially motivated: decreased pain positively reinforces inappropriate behaviors Socially motivated: mom s attention further positively reinforces behavior
17 why did he do that? Ex. Kristin tantrums each time the teacher begins to work with her classmates Form: tantrums Function: gain desired outcome (i.e., teacher attention) Q: What would positively reinforce this behavior? Q: What would negatively reinforce this behavior?
18 why did he do that? Antecedents Setting events (context)? Antecedent stimulus (trigger)? Behaviors Response to stimulus? Consequences Maintaining consequence (reinforcers)?
19 should I be worried? TYPICAL VERSUS ATYPICAL SCREENING
20 should I be worried? When it s too odd, too often, too much Hyperactivity-impulsivity Anxiety Obsessive-compulsive behaviors Mood problems Aggression (verbal and physical) Self-injury
21 should I be worried? first stage screening second stage screening Brief Infant-Toddler Social & Emotional Assessment (BITSEA) Ages & Stages: Social-Emotional (ASQ:SE) Pediatric Symptom Checklist (PSC) Eyberg Child Behavior Inventory (ECBI) Pediatric Intake Form (a.k.a., Family Psychosocial Screen)
22 Pediatric Symptom Checklist General psychosocial screen [Jellinek, MD; Murphy, EdD] Ages 4-16 years Parent & self report (>9 years old) 35 items 7 minutes English, Spanish and many others Provides cut-off (including Attention, Internalizing, Externalizing subscales) Sensitivity 80-95%; specificity % px
23 should I be worried? When it s not within normal limits first stage screening second stage screening
24 should I be worried? first stage screening second stage screening Child Behavior Checklists (CBCL, TRF, C-TRF, YRF) Behavior Assessment Scale for Children, Second Edition (BASC-2) Infant-Toddler Social & Emotional Assessment (ITSEA)
25 what is going on? EVALUATION
26 what is going on? Appropriate referral for evaluation Evaluation consists of History Key clinical questions Clinical interview or observation Standardized questionnaires Differential diagnosis DSM-IV-TR criteria
27 standardized questionnaires ADHD: NICHQ Vanderbilt Assessment Scale Conners, 3 rd Edition (Conners 3) ADD-H Comprehensive Teacher s Rating Scale (ACTeRS), Second Edition Others: See attachment from Massachusetts General Hospital ools_table.asp
28 what should I do? MANAGEMENT
29 multimodal management Developmental assessment/supports Environmental assessment/supports Functional behavioral analysis Parenting skills Educational supports Behavioral and other therapies Psychopharmacotherapy
30 specific disorders ADHD ODD ANXIETY DISORDERS MOOD DISORDERS
31 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls 4-6% prevalence Higher in lower SES Male:female estimated at 2:1 Etiology Genetic factors Medical risk factors Prognosis Symptoms persists into adulthood, but change over time Better if treated, no co-morbid behavior disorders, higher IQ, higher SES
32 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Presentation: ADHD-IA: academic problems ADHD-HI: conduct problems ADHD-CT: both 3-5 years 6-8 years ADHD-CT, -HI ADHD-IA severe mild home school social +/- safety +/-
33 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Clinical observation* Physical examination* Diagnosis is by DSM-IV-TR criteria Other studies if indicated: Psychoeducational if learning disability suspected Neurological (e.g., EEG) if neurological condition suspected * Often not helpful
34 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Pharmacologic mainstay Stimulants Atomoxetine Alpha-agonist Certain atypical antidepressants Guidelines Texas Children s Medication Algorithm Project [Pliszka et al, 2006] Psychopharmacological Treatment for Very Young Children [Gleason et al, 2007]
35 Pliszka et al, JAACAP, 2006, 45(6): 642
36 Pliszka et al, JAACAP, 2006, 45(6): 642
37 ADHD medication guide
38 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Non-pharmacologic Parenting (or parent training) especially in preschool aged children Psychotherapy if co-morbidity Complementary & alternative Refer if Not responsive to medications Persistent, unacceptable side effects Diagnosis is not clear
39 ADHD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Diagnostic certainty is impossible Co-morbidities are common Myths and misconceptions are common Goal is reducing morbidities (home, school, social, safety) Be familiar with the pharmacokinetics Care coordination improves prognosis
40 ODD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Recurrent pattern of negativistic, disobedient, hostile behaviors 2-16% prevalence Higher in males Etiology Genetic factors (slight) Environmental factors (significant) Temperamental factors (significant) Co-morbidities Behavioral: ADHD, mood, conduct Developmental: language disorders
41 ODD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Presentation Onset<3 years old, increases with age Worse in>out of the home Symptoms Tantrums Persistent stubbornness Resistance to directions Inflexibility Deliberate, persistent testing of limits Verbal>physical aggression Labile mood Low frustration tolerance Low self-image
42 ODD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Clinical observation (in vitro)* Physical examination* Diagnosis is by DSM-IV-TR criteria Other studies if indicated: Speech-language if speech-language disorder suspected Psychoeducational if developmental or learning disability suspected * Often not helpful
43 ODD overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Advice on behaviors* Rather, focus on other anticipatory issues (e.g., exposure to violence) Counseling mainstay Psychologist Licensed professional counselor Goal is to reduce symptoms Parenting (or parent training) Family therapy Cognitive-behavioral therapy Collaborative problem solving (Pharmacologic) * Often not helpful
44 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls 13% prevalence Most common psychiatric disorder 33% have 2 other anxiety disorders Etiology: Genetic factors Environmental factors Temperamental factors Prognosis: Often chronic, persistent into adulthood
45 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Types: Simple phobia (10-11%) Generalized anxiety disorder (3-10%) Obsessive compulsive disorder (2.5%) Separation anxiety disorder (4%) Social phobia (10-11%) Generalized versus non-generalized Selective mutism Posttraumatic stress disorder (1-14%) Panic disorder ( %)
46 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Presentation: Cognitive catastrophic thoughts, poor school performance Physical nausea, pain, headaches, eating problems, sleeping problems Emotional fears, worry Behavioral avoidance, escape, emotional outbursts Ask about Duration, frequency, intensity Anticipatory vigilance?
47 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls DDX: Developmentally appropriate worries and fears Medical conditions (due to somatic complaints) Medication side effects Learning d/o (e.g., school refusals) Developmental d/o (resulting in younger mental age)
48 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management History Clinical observation* Physical examination* DSM-IV-TR criteria Other studies if indicated: Medical evaluations to rule-out medical condition pearls & pitfalls * Often not helpful
49 anxiety disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Non-pharmacologic mainstay Parenting (or parent training), for children <8 years old Cognitive-behavioral therapy, for children >8 years old Pharmacologic When severe impairment in functioning Options: SSRI, atypical antidepressants, (benzodiazepines) Educational Supports Special Education under Emotional Disturbance
50 anxiety disorders overview signs & symptoms differential diagnosis Internalizing disorders are easier to under-recognize Often co-morbid externalizing disorders Have more contextual clues diagnosis management pearls & pitfalls
51 depressive disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls 1-8% prevalence Etiology/risk factors: Genetic Environmental Neurodevelopmental factors/stages Medical 60-80% co-morbidities Types: Major Depressive Disorder Dysthymic Disorder
52 depressive disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Depressive episode: 2 weeks of 5 symptoms of: *Depressed mood *Markedly diminished interest or pleasure Significant weight loss or gain, or decrease or increase in appetite Insomnia or hypersomnia Psychomotor agitation or retardation Fatigue or loss of energy Feelings of worthlessness or excessive or inappropriate guilt Diminished ability to think or concentrate, or indecisiveness Recurrent thoughts of death, recurrent suicidal ideation, or suicide attempt
53 depressive disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Presentation: Infants/toddlers passive & unresponsive to irritable & inconsolable School aged irritability, withdrawn, somatic, morbid preoccupation Adolescents intense negative feelings, leading to irritability, anger, resentment, and self-harm DDX: Medical conditions Substances
54 depressive disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls History Direct, private discussion with children and adolescents Clinical observation Physical examination* DSM-IV-TR criteria Other studies if indicated: Medical evaluations to rule-out medical conditions, substances * Often not helpful
55 depressive disorders overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Setting Primary care provider for mildmoderate depression Mental health professionals for moderate-severe depression Immediate psychiatric evaluation if suicidal, psychotic, abusing substances Non-pharmacologic mainstay Counseling Psychosocial interventions Pharmacologic SSRI, (TCA)
56 bipolar disorder overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls True prevalence unknown Etiology/risk factors: Genetic Neurodevelopmental factors/stages Environmental 60-80% co-morbidities ADHD, conduct disorder, anxiety, substance abuse Prognosis Typically chronic, lifelong Often partial recovery, frequent relapse
57 bipolar disorder overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Manic episode: 1 week of 3 symptoms of Abnormal mood: euphoria + irritability (extreme, persistent, threatening, out-ofcontrol, rages) Distractibility Increased activity/energy Grandiosity Flight of ideas Activities with bad outcome Sleep decreased Talkativeness Can be Mixed, Hypomanic episodes
58 bipolar disorder overview signs & symptoms History Clinical observation Physical examination* DSM-IV-TR criteria differential diagnosis diagnosis management pearls & pitfalls * Often not helpful
59 bipolar disorder overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Goal: Control mania (and depression) Develop insight Adhere to medications, prevent relapse Address co-morbidities Pharmacologic mainstay Mood-stabilizers Combined treatments typically needed Non-pharmacologic Counseling
60 bipolar disorder overview signs & symptoms differential diagnosis Mood-stabilizers Atypical antipsychotics Lithium Certain anticonvulsants (valproate, carbamezapine, oxycarbamezapine, lamotrigine) diagnosis management pearls & pitfalls
61 bipolar disorder overview signs & symptoms differential diagnosis diagnosis management pearls & pitfalls Pediatric mania is More irritability than euphoria More mixed states and complex cycling More chronic More co-morbidities Parenting does not cause BPD Parents may see it first Antidepressants, stimulants can exacerbate mania
62 stimulants Generic methylphenidate dexmethylphenidate Brand Ritalin, Ritalin SR, Ritalin LA Metadate CD, Metadate ER Methylin, Methylin ER Concerta, Daytrana Focalin, Focalin XR dextroamphetamine Dextrostat, Dexedrine, Dexedrine spansules amphetamine salts Adderall, Adderall XR
63 2 adrenergic agonists Generic Brand clonidine Catapres, Kapvay guanfacine Tenex, Intuniv noradrenergic reuptake inhibitpr Generic Brand atomoxetine Strattera
64 SSRI antidepressants Generic Brand T 1/2 Steady state fluoxetine Prozac hrs 5 weeks paroxetine Paxil 21 hrs 7-10 days sertraline Zoloft 26 hrs 7-10 days fluvoxamine Luvox 16 hrs 7-10 days citalopram Celexa 36 hrs 7-10 days escitalopram Lexapro hrs 7-10 days SSRI = selective serotonin reuptake inhibitor
65 atypical antidepressants Generic Brand buspirone Buspar clomipramine Anafranil bupropion Wellbutrin, Wellbutrin XR mirtazapine Remeron venlafaxine Effexor, Effexor XR imiprimine Tofranil nortriptyline Pamelor nefazodone Serzone trazodone Desyrel
66 atypical neuroleptics Generic Brand risperdone (H) Risperdal olanzepine (M) Zyprexa quetiapine (M) Seroquel aripiprazole (L) Abilify ziprasidone (M) Geodon clozapine (L) Clozaril L=low potency; M = medium or intermediate potency; H=high potency
67 antiepileptic & mood stabilizers Generic Brand lithium carbonate Lithobid carbamazepine Tegretol oxcarbazepine Trileptal valproate Depakote lamotrigine Lamictal gabapentin Neurontin topiramate Tpopmax clonazepam Klonopin
68 final comments Your role is helping decide typical from atypical. There are tools available to you. Make the diagnosis. Manage the condition.
Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More informationGuide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationSchedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
More informationPSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationChild & Adolescent Psychiatry (a brief overview)
Child & Adolescent Psychiatry (a brief overview) Lance Feldman, MD, FAPA, MBA, BSN Vice Chair Clinical Affairs, Department of Psychiatry Affiliate Clinical Assistant Professor, University of South Carolina
More informationRichard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationMental Health Nursing: Mood Disorders. By Mary B. Knutson, RN, MS, FCP
Mental Health Nursing: Mood Disorders By Mary B. Knutson, RN, MS, FCP A Definition of Mood Prolonged emotional state that influences the person s whole personality and life functioning Adaptive Functions
More informationTRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY
TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient
More informationCreating Partnerships. Laine Young-Walker, MD
Creating Partnerships Laine Young-Walker, MD Psychiatry is the medical specialty devoted to the study, diagnosis, treatment and prevention of mental disorders. Medical school >>>four years of residency
More informationIMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
More informationMental Health Intake Form
Current Symptoms Checklist: (check once for any symptoms present, twice for major symptoms) ( ) ( ) Depressed mood ( ) ( ) Racing thoughts ( ) ( ) Excessive worry ( ) ( ) Unable to enjoy activities ( )
More informationMedically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
More informationMental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling
Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting
More informationChange Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness
Change Your Brain, Change Your Life The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Daniel G Amen Three Rivers Press New York Appendix Medication 1.
More informationHappy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?
Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms
More informationMental Health Intake Form
38600 Van Dyke Ave., Suite 200 Sterling Heights, MI 48313 Phone: (586) 933-5395 Fax: (586) 935-0159 Mental Health Intake Form Please complete all information on this form and bring it to the first visit.
More informationThe Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD
The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD Damon Korb, MD Behavioral and Developmental Pediatrician Director of the Center for Developing Minds Los Gatos,
More informationManaging the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center
Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Abstract: The majority of boys and many girls with fragile X
More informationDepression. University of Illinois at Chicago College of Nursing
Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More informationAutism: Improving Health Care Outcomes
AUTISM AWARESS CONFERENCE Lewis County Autism Coalition 23 September 2011 Autism: Improving Health Care Outcomes Glenn C. Tripp, M.D. Developmental Behavioral Pediatrics Medical Director, Developmental
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More information6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.
Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders
More informationAD/HD is a mental disorder, and it often lasts from
short version10 WHAT WE KNOW Managing Medication for Adults with AD/HD AD/HD is a mental disorder, and it often lasts from childhood into adulthood. Medication is the basic part of treatment for adults.
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX
A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationAre All Older Adults Depressed? Common Mental Health Disorders in Older Adults
Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and
More informationOverview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
More informationThe Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders
The Mental Health and Wellbeing of Children and Adolescents who are affected by Autism and Related Disorders Charles Cartwright, M.D Director: YAI Autism Center March 2013 Autism Spectrum Defined by the
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder
Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM
Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationDealing with a Mental Health Crisis
Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to
More informationThe Use of ADHD Medication in the Pediatric Population
The Use of ADHD Medication in the Pediatric Population Shirin Madzhidova, PharmD Pediatric Pharmacotherapy Fellow Nova Southeastern University Objectives Discuss the importance of treatment with medications
More informationAttention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6
in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,
More informationBrief Notes on the Mental Health of Children and Adolescents
Brief Notes on the Mental Health of Children and Adolescents The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More informationADHD and. Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry
ADHD and Beyond Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry Overview Use of medications in children How do medications work in the brain? Risperdal?
More informationMedications in Autism: What We Know and Don't Know
Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
More informationFROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY
13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD
More informationAppendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
More informationBehavioral Health. Behavioral Health. Prescribing Guidelines
Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine
More informationAdult Initial Assessment / Patient Questionnaire Page 1
Page 1 Patient Name: Date: Age: Date of Birth: / / Please read the following questions and answer to the best of your ability by placing a checkmark in the appropriate boxes or filling in the blank as
More informationManagement Of Depression And Anxiety
Management Of Depression And Anxiety CME Financial Disclosure Statement I, or an immediate family member including spouse/partner, have at present and/or have had within the last 12 months, or anticipate
More informationWe ll Be Discussing. Pregnancy 4/24/2013
Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free monthly e-newsletter? We ll Be Discussing The safety and efficacy track
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationTreating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers
Treating Disruptive Behavior Disorders in Children and Teens A Review of the Research for Parents and Caregivers e Is This Information Right for Me? This information is for you if: A health care professional*
More informationMood Disorders for Care Coordinators
Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders
More informationWelcome and thank you for choosing University of Florida Physicians!
DEPARTMENT OF PSYCHIATRY Tuesday, Division of March Child and 14, Adolescent 2017 Psychiatry 8491 NW 39 th Ave. Gainesville, FL 32606 Phone: 352-265-4357 Fax: 352-627-4163 Welcome and thank you for choosing
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationADHD Medications Table
Stimulants are the first line treatment of choice for ADHD followed by Non-Stimulants, then off-label medications. We are providing this list of medications so that you can be familiar with the common
More informationPsychotropic Medications in Children and Adolescents: Guide for Use and Monitoring
Psychotropic Medications in Children and Adolescents: Guide for Use and This document was developed by Community Care of North Carolina with the assistance of the Medication Management Workgroup of the
More informationPrepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.
Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Sources: National Institute of Mental Health (NIMH), the National Alliance on Mental Illness (NAMI), and from the American Psychological Association
More informationPediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline
Pediatric Primary Care Mental Health Specialist Certification Exam Detailed Content Outline Description of the Specialty The Pediatric Primary Care Mental Health Specialist (PMHS) builds upon the Advanced
More informationUSF Health Psychiatry Clinic. New Patient Questionnaire Adult
USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days
More informationTreatment of Children with Mental Disorders
Treatment of Children with Mental Disorders Children are in a state of rapid change and growth during their developmental years. Diagnosis and treatment of mental disorders must be viewed with these changes
More informationOhio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of
Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,
More informationExplosive Youth: Common Brain Disorders. Juvenile Law Conference 2005 Larry Fisher, Ph.D. UHS Neurobehavioral Systems
Explosive Youth: Common Brain Disorders Juvenile Law Conference 2005 Larry Fisher, Ph.D. UHS Neurobehavioral Systems For More Information Larry Fisher, Ph.D. Director of Neuropsychological Services UHS
More informationMedications, By Class, in TBI
Medications, By Class, in TBI Generic/Brand Name Drawback Advantage Mood Stabilizers (anti-seizure medications) Carbamazepine (Carbatrol ) (Equetro ) (Tegretol ) Gabapentin (Neurontin ) Lamotrigine (Lamictal
More information7/9/2013. Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly. What ADHD is
Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony
More informationPractice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,
Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Journal of the Academy of Child and Adolescent Psychiatry, 1997 Primary Authors: Jon McClellan MD
More informationJohn E. Kraus, M.D., Ph.D.
John E. Kraus, M.D., Ph.D. Chief, Adult Psychiatry, Dorothea Dix Hospital, Raleigh, NC Assistant Professor/Associate Director of Residency Training, Dept. of Psychiatry, UNC Hospitals, Chapel Hill, NC
More informationDEPRESSION. Men and women of all ages, races, and economic levels can have depression. It occurs more often in women.
DEPRESSION The exact cause of depression is not known. Many researchers believe it is caused by chemical imbalances in the brain, which may be hereditary or caused by events in a person's life. Some types
More informationTourette Syndrome. Biological Basis, Clinical Symptoms, Treatment. Drake D. Duane, MS, MD
Tourette Syndrome Biological Basis, Clinical Symptoms, Treatment Drake D. Duane, MS, MD Director, Institute for Developmental Behavioral Neurology Adjunct Professor, Arizona State University Scottsdale/Tempe,
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationASD Autism Spectrum Disorder
Psychopharmacology and Autism Spectrum Disorder Bennett L. Leventhal, MD Professor Department of Psychiatry University of California, San Francisco Sources of Research Support NIH Simons Foundation Janssen
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationHumberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor
The Carter Jenkins Center presents 1 Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor Emeritus of Psychiatry
More informationAAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders
More informationSteps for Initiating Electroconvulsive Therapy Treatment
Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral
More information5/2/2017. By Pamela Pepper PMH, CNS, BC. DSM-5 Growth and Development
By Pamela Pepper PMH, CNS, BC DSM-5 Growth and Development The idea that diagnosis is based on subjective criteria and that those criteria should fall neatly into a set of categories is not sustainable,
More informationWhere to from Here? Evidence-Based Strategies for Treatment of Refractory Depression
Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Major Depression #1 WHO cause of disability
More informationPartners in Care Quick Reference Cards
Partners in Care Quick Reference Cards Supported by the Agency for Healthcare Research and Quality MR-1198/8-AHRQ R This project was funded by the Agency for Healthcare Research and Quality (AHRQ), formerly
More informationMental Health Medications. National Institute of Mental Health. U.S. Department of HealtH and HUman ServiceS National Institutes of Health
Mental Health Medications National Institute of Mental Health U.S. Department of HealtH and HUman ServiceS National Institutes of Health Contents Mental Health Medications...1 What are psychiatric medications?...1
More informationAdult Depression - Clinical Practice Guideline
1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)
More informationNorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
More informationPractical Psychopharmacology for More Complex Mental Health Presentations
MINISTRY OF CHILDREN AND YOUTH SERVICES Practical Psychopharmacology for More Complex Mental Health Presentations Part 1: Stimulants Dr. Ajit Ninan & Joel Lamoure 1 Practical Psychopharmacology for More
More informationEvidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center
Evidence-Based Pharmacotherapy Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center CME Disclosure I have no personal financial relationships in any commercial interest related to
More informationAsk The Shrink: ADHD
Ask The Shrink: ADHD Theodore A. Petti, MD Professor of Psychiatry Division of Child and Adolescent Psychiatry Robert Wood Johnson Medical School PPC Hub Psychiatrist Hackensack Meridian Hubs @ Saint Peter'
More informationPsychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition
Psychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition Presented by Cat Dang, D.O Medical Director - Insightful Minds, Inc. Objectives Evaluation process Pharmacology
More informationPsychopharmacology: An Overview
Psychopharmacology: An Overview John Tanquary, M.D. Clinical Assistant Professor Department of Psychiatry Upstate Medical University Psychpharmacology Consultant Le Moyne College Syracuse University Financial
More informationDepression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms
Depression and Anxiety By Christopher Okiishi, MD Spring 2016 What is Depression? Not just being sad A syndrome of symptoms Depressed mood Sleep disturbance Decreased interest in usual activities (anhedonia)
More informationDepression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder:
Depression major depressive disorder Oldest recognized disorder: melancholia It is a positive and active anguish, a sort of psychical neuralgia wholly unknown to normal life. - William James "I am now
More informationPsychiatric medication treatment in children and adolescents:
Psychiatric medication treatment in children and adolescents: The good, the bad and the ugly Gabrielle A. Carlson, MD Professor of Psychiatry and Pediatrics Director, Child and Adolescent Psychiatry Stony
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationBig Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
More informationPediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016
Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016 Good psychopharmacology depends on Proper use of safe and effective meds Treatment of other obvious factors (e.g., medical conditions, toxic
More informationDrugs for Emotional and Mood Disorders Chapter 16
Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,
More information2013 Virtual AD/HD Conference 1
Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com
More informationIntroductory discussion
Billina R. Shaw, MD Assistant Professor University of Maryland School of Medicine Department of Psychiatry Division of Child and Adolescent Psychiatry Introductory discussion Prescribing trends in foster
More informationPsychiatric Issues in Huntington s Disease
Psychiatric Issues in Huntington s Disease Arik Johnson, PsyD HDSA Center of Excellence at UCLA June 24, 2011 26th Annual HDSA Conference Minneapolis, MN The information provided by speakers in workshops,
More information